The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 3, 2011, Pages

  Noda, Takeshi ^a   Kolesnikova, Larissa ^b   Becker, Stephan ^b   Kawaoka, Yoshihiro ^a,b,c,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP35; RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN; VIRUS PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; EBOLA VIRUS; FILOVIRUS INFECTION; HUMAN; HUMAN CELL; MORPHOGENESIS; NUCLEOPROTEIN PROTEIN VP35 RATIO; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VIRAL PHENOMENA AND FUNCTIONS; VIRUS INCLUSION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

EBOLAVIRUS; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HUMANS; INCLUSION BODIES; NUCLEOCAPSID PROTEINS; RNA, VIRAL; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 80054734483     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir310     Document Type: Article

References (36)

1. Sanchez A, Khan AS, Zaki SR, Nabel GJ, Ksiazek TG, Peters CJ. Filoviridae: Marburg and 'Ebola viruses. In : Knipe DM, Howley PM, Griffin DE, eds. . Fields virology. 4th ed. Philadelphia: Lippincott- Raven, 2001; 1279-304.
2. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A 2000; 97:13871-6.
3. Timmins J, Scianimanico S, Schoehn G, Weissenhorn W. Vesicularrelease of ebola virus matrix protein VP40. Virology 2001; 283:1-6. (Pubitemid 32911504)
4. Noda T, Sagara H, Suzuki E, Takada A, Kida H, Kawaoka Y. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol 2002; 76:4855-65. (Pubitemid 34441691)
5. Mühlberger E,Weik M, Volchkov VE, Klenk HD, Becker S. Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol 1999; 73:2333-42. (Pubitemid 29098138)
6. Weik M, Modrof J, Klenk HD, Becker S, Mühlberger E. Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol 2002; 76:8532-9. (Pubitemid 34864047)
7. Basler CF, Wang X, Mühlberger E, et al. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 2000; 97:12289-94.
8. Basler CF, Mikulasova A, Martinez-Sobrido L, et al. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 2003; 77:7945-56. (Pubitemid 36792791)
9. Cárdenas WB, Loo YM, GaleMJr, et al. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 2006; 80:5168-8.
10. Hartman AL, Dover JE, Towner JS, Nichol ST. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. J Virol 2006; 80:6330-40.
11. Prins KC, Cárdenas WB, Basler CF. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J Virol 2009; 83:3069-77.
12. Reid SP, Cárdenas WB, Basler CF. Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. Virology 2005; 341:179-89. (Pubitemid 41416728)
13. Feng Z, Cerveny M, Yan Z, He B. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNAdependent protein kinase PKR. J Virol 2007; 81:182-92. (Pubitemid 44975159)
14. Schümann M, Gantke T, Mühlberger E. Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J Virol 2009; 83:4508-19.
15. Haasnoot J, de Vries W, Geutjes EJ, Prins M, de Haan P, Berkhout B. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 2007; 3:e88.
16. Becker S, Rinne C, Hofsäss U, Klenk HD, Mühlberger E. Interactions of Marburg virus nucleocapsid proteins. Virology 1998; 249:406-17. (Pubitemid 28460892)
17. Groseth A, Charton JE, Sauerborn M, et al. The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified. Virus Res 2009; 140:8-14.
18. Huang Y, Xu L, Sun Y, Nabel GJ. The assembly of ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol Cell 2002; 10:307-16. (Pubitemid 35007345)
19. Noda T, Ebihara H, Muramoto Y, et al. Assembly and budding of Ebolavirus. PLoS Pathog 2006; 2:e99.
20. Watanabe S, Noda T, Kawaoka Y Functional mapping of the nucleoprotein of Ebola virus. J Virol 2006; 80:3743-51.
21. Noda T,Hagiwara K, Sagara H, Kawaoka Y. Characterization of the Ebola virus nucleoprotein-RNA complex. J Gen Virol 2010; 91:1478-83.
22. Masters PS, Banerjee AK. Complex formation with vesicular stomatitis virus phosphoprotein NS prevents binding of nucleocapsid protein N to nonspecific RNA. J Virol 1988; 62:2658-64.
23. Green TJ, Macpherson S, Qiu S, Lebowitz J, Wertz GW, Luo M. Study of the assembly of vesicular stomatitis virus N protein: role of the P protein. J Virol 2000; 74:9515-24.
24. Chen M, Ogino T, Banerjee AK. Interaction of vesicular stomatitis virus P and N proteins: identification of two overlapping domains at the N terminus of P that are involved in N0-P complex formation and encapsidation of viral genome RNA. J Virol 2007; 81:13478-85. (Pubitemid 350247842)
25. Brzó zka K, Finke S, Conzelmann KK. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 2005; 79:7673-81. (Pubitemid 40756801)
26. Brzó zka K, Finke S, Conzelmann KK. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J Virol 2006; 80:2675-83. (Pubitemid 43346363)
27. Mellon MG, Emerson SU. Rebinding of transcriptase components (L and NS proteins) to the nucleocapsid template of vesicular stomatitis virus. J Virol 1978; 27:560-7. (Pubitemid 9009095)
28. Emerson SU, Schubert M. Location of the binding domains for the RNA polymerase L and the ribonucleocapsid template within different halves of the NS phosphoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A 1987; 84:5655-9.
29. Gill DS, Chattopadhyay D, Banerjee AK. Identification of a domain within the phosphoprotein of vesicular stomatitis virus that is essential for transcription in vitro. Proc Natl Acad Sci U S A 1986; 83:8873-7. (Pubitemid 17223503)
30. Chenik M, Schnell M, Conzelmann KK, Blondel D. Mapping the interacting domains between the rabies virus polymerase and phosphoprotein. J Virol 1998; 72:1925-30. (Pubitemid 28100745)
31. Fu ZF, Zheng Y, Wunner WH, Koprowski H, Dietzschold B. Both the N- and the C-terminal domains of the nominal phosphoprotein of rabies virus are involved in binding to the nucleoprotein. Virology 1994; 200:590-7. (Pubitemid 24146535)
32. Jacob Y, Badrane H, Ceccaldi PE, Tordo N. Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein. J Virol 2000; 74:10217-22.
33. Kubota T, Matsuoka M, Chang TH, et al. Ebolavirus VP35 interacts with the cytoplasmic dynein light chain 8. J Virol 2009; 83:6952-6.
34. Noda T, Watanabe S, Sagara H, Kawaoka Y.Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus. J Virol 2007; 81:3554-62. (Pubitemid 46456664)
35. Björndal AS, Szekely L, Elgh F. Ebola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cells. BMC Microbiol 2003; 3:6.
36. Iverson LE, Rose JK. Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell 1981; 23:477-84. (Pubitemid 11096341)